Such an exchange of information and publicity will promote our mi

Such an exchange of information and publicity will promote our missions, collaboration Vadimezan clinical trial and

coordination in this area. The 4th AFCKDI meeting will be held in Seoul on 4 June 2010 to discuss results of these work groups. We need to expand our network of collaborative initiative to broader areas and countries in order to make this initiative truly representative of our region. “
“The Northern Hospital, Epping, Vic., Australia “
“Novartis is delighted to report on the renal cases program held in 2011. The program was initiated with the aim of fostering and sharing innovation, development and the highest standards in the understanding and clinical management of renal transplantation in Australia. This initiative was developed as part of the Novartis commitment to encouraging interest and education in the practice of Transplant Nephrology. Entries for these awards could be made by any RACP Nephrology Advance Trainee currently working in Australia. The case reports submitted for the program were judged

by an independent panel of distinguished Nephrologists who selected the top five case reports according to: Scientific interest We are delighted to sponsor the publication of the top five cases, as chosen by the Panel, to be published in no particular order in this supplement of Nephrology. Novartis Crenolanib mw looks forward to providing more innovative programs as part its commitment to excellence in the practice and research within the field of transplantation. old
“On behalf of the Asian Pacific Society of Nephrology (APSN) and Japanese Society of Nephrology (JSN), I am pleased to welcome you to the 14th Asian

Pacific Congress of Nephrology (APCN), May 14–17, 2014. The APSN aims to promote and encourage the advancement of scientific knowledge and research in all aspects of nephrology, and to promote the exchange and dissemination of this knowledge in the Asian-Pacific area. We would like to encourage you to join us in discussing the many issues surrounding inflammatory or metabolic renal diseases, acute kidney injury (AKI), and renal replacement therapy (RRT). The three main symposia of APCN 2014 will cover the fields of IgA nephropathy, diabetic nephropathy, and chronic kidney disease (CKD). Moreover, at APCN 2014 we will continue our planned collaboration with the JSN 2013 and APCN 2014 Cooperative Project – the Young Investigators Award for Asian Nephrologists (YIAAN) Session – in order to enhance support for young nephrologists from Asia. This gives opportunities to more researchers than ever before the benefit of learning about various researches from all over Asia. More than 550 abstracts from 24 countries have been accepted for either oral or poster presentations. A wide choice of symposium and CME programs focused on the various fields of basic and clinical nephrology will run throughout the congress.

Comments are closed.